Compare CAPL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAPL | BVS |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.5M | 716.8M |
| IPO Year | 2012 | 2016 |
| Metric | CAPL | BVS |
|---|---|---|
| Price | $22.02 | $8.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 44.1K | ★ 678.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 9.96% | N/A |
| EPS Growth | 96.15 | ★ 163.46 |
| EPS | ★ 0.26 | 0.04 |
| Revenue | ★ $1,869,806,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | $2.80 | $7.06 |
| P/E Ratio | ★ $83.54 | $218.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.61 | $5.81 |
| 52 Week High | $23.34 | $11.25 |
| Indicator | CAPL | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 43.86 |
| Support Level | $21.53 | $8.43 |
| Resistance Level | $23.01 | $9.27 |
| Average True Range (ATR) | 0.56 | 0.38 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 49.83 | 57.14 |
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments, namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.